Dose Optimization in Elderly CML Patients Treated with Bosutinib after Intolerance or Failure of First-Line Tyrosine Kinase Inhibitors

出版年份 2020 全文链接

标题

作者

关键词

出版物

Volume 134, Issue Supplement_1, Pages 496-496

出版商

American Society of Hematology

发表日期

2020-02-14

DOI

10.1182/blood-2019-127514

Discuss science. Find collaborators. Network.

Join a conversation

Explore over 38,000 international journals covering a vast array of academic fields.